AMSBIO has assembled an extensive collection of autophagy antibodies.

From the industry standard autophagy antibody APG8 (MAPLC3) to the newest autophagy antibodies such as LAMP and APG1, AMSBIO is able to provide the most relevant, qualified antibodies for autophagy research.

Autophagy is a cellular process not only implicated in the death of a cell, but more widely implicated in the survival of a cell. Autophagy functions as a housekeeping mechanism through disposal of aging and/or dysfunctional proteins and organelles by isolating and preparing these proteins for lysosomal degradation. Targeting autophagy as a therapeutic method is of growing interest to many researchers specializing in a diverse range of diseases from bacterial and viral infections to cancer and more recently in neurodegeneration and other ageing-related diseases.

Mitochondrial dysfunction has also become increasingly linked to various diseases, with mitophagy playing an important role in mitochondrial dynamics. AMSBIO provide a MitoXpress® Xtra Oxygen Consumption Assay for analysis in real-time of mitochondrial function using fluorescence plate readers.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective. Custom services include stable cell line production, CRISPR/Cas9 Genome Editing, lentivirus and adenovirus production, large scale protein production and a comprehensive portfolio of antibody services.

more about AMS biotechnology

more news from AMS biotechnology